869.2000 -5.90 (-0.67%)
NSE Jun 23, 2025 15:31 PM
Volume: 353.3K
 

869.20
-0.67%
HDFC Securities
Natco Pharma Ltd Q3FY18 results comment Revenue grew by 31.76% to Rs. 562.2 Cr in Q3FY18 when compared to the previous quarter. On the other hand, it decreased by 16.08% when compared with Q3FY17.
Natco Pharma Ltd. is trading below its 30 day SMA of 872.6
More from Natco Pharma Ltd.
Recommended